Interacting Drugs |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs RimabotulinumtoxinB |
Security Level |
 |
Mechanism |
RimabotulinumtoxinB: Anticholinergic Agents may enhance the anticholinergic effect of RimabotulinumtoxinB. |
Management |
Monitor therapy |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs RimabotulinumtoxinB
Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs RimabotulinumtoxinB Click here to cancel reply.
Other Interactions of Hyoscyamine, atropine, scopolamine, and phenobarbital
Other Interactions of RimabotulinumtoxinB
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.